We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Milk Components on the Response to the Pneumonia Vaccine in Senior Citizens

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01626300
First Posted: June 22, 2012
Last Update Posted: June 21, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of California, Davis
  Purpose
The purpose of this study is to determine if the daily use of a certain amount and type of milk component for 2 months provides a significant stimulation to the immune system and specifically increases the chances of being protected against pneumonia after the vaccination.

Condition
The Effect of Milk Components on the Response to Pneumococcal Vaccines in the Elderly

Study Type: Observational
Study Design: Observational Model: Case-Control
Time Perspective: Retrospective
Official Title: The Effect of Milk Components on the Response to the Pneumonia Vaccine in Senior Citizens: A Randomized Placebo-controlled Clinical Trial

Resource links provided by NLM:


Further study details as provided by University of California, Davis:

Enrollment: 45
Study Start Date: December 2007
Study Completion Date: June 2008
Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   60 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Healthy subjects > 60 years of age.
Criteria

Inclusion Criteria:

  • Age and a willingness to participate

Exclusion Criteria:

  • • Smoking history within 10 years

    • Underlying neoplasia or immunological disease
    • Use of oral cortisone or other immunosuppressive agents
    • Current consumption of milk and milk products greater than 1 unit of milk, 1 yogurt, or 1 serving of fresh cheese a day.
    • Food faddists or those taking a non-traditional diet
    • Current consumption of dietary supplements
    • People with a known history of milk allergy
    • People with chronic renal failure
    • People with chronic inflammatory diseases taking daily doses of NSAIDs for longer than 4 weeks at the time of enrollment.
    • Previous administration of the pneumomax vaccine
    • Reduced physical activity (i.e. NYHA classes III-IV)
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: University of California, Davis
ClinicalTrials.gov Identifier: NCT01626300     History of Changes
Other Study ID Numbers: 200513884
First Submitted: June 20, 2012
First Posted: June 22, 2012
Last Update Posted: June 21, 2017
Last Verified: May 2017

Additional relevant MeSH terms:
Pneumonia
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections